Element Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Element Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,080	Closed	-$192K	–	835
2019 Q1	$192K	Sell	13,080 -6,895	-35%	-$79.2K	0.01%	757
2018 Q4	$214K	Buy	+19,975	New	+$263K	0.01%	552
2018 Q2	–	Sell	-82,957	Closed	-$793K	–	1070
2018 Q1	$793K	Buy	+82,957	New	+$894K	0.02%	231

Other funds holding DRNA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Element Capital Management's DRNA Position: Q2 2019 in Review

Element Capital Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q2 2019, closing a stake of 13,080 shares — an estimated $192K sold.

Element Capital Management first reported a position in DRNA in Q1 2018 and held it in 3 quarters. The position peaked at $793K in Q1 2018. 98 funds tracked by Wall St. Rank hold DRNA as of Q2 2019.

Element Capital Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Element Capital Management sold 13,080 Dicerna Pharmaceuticals, Inc. shares in Q2 2019, an estimated $192K.
Element Capital Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2018 and held it in 3 quarters.
Element Capital Management's Dicerna Pharmaceuticals, Inc. position peaked at $793K in Q1 2018.
98 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2019.

Based on Element Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.